Javascript must be enabled to continue!
Platelet-rich plasma fibrin glue for treatment of chylothorax following cavopulmonary connections
View through CrossRef
Abstract
OBJECTIVES
The postoperative persistence of chylothorax is a fatal complication of paediatric cardiac surgery. There is an urgent need for an effective treatment of chylothorax. This study reports the application of allogenic platelet-rich plasma fibrin glue (PRP-FG) as a conservative therapy before reoperation.
METHODS
Over a 9-year period, from 2010 to 2019, 27 patients with persistent chylothorax following a cavopulmonary connection, with a mean latency period of 11 days (range 10–15 days), were treated with PRP-FG. These patients were selected because they had not responded positively to initial conservative management plans. The patients were followed up for 9 years.
RESULTS
Twenty-five patients (92%) responded positively to treatment with PRP-FG; 2 patients did not respond to the treatment and died after reoperation. All of the successfully treated patients in follow-up continued to live a healthy life without further complications.
CONCLUSIONS
Recalcitrant chylothorax that persists after paediatric cardiac surgery responded positively to treatment with PRP-FG. This technique precluded the need for another operation and significantly decreased the morbidity and mortality rates.
Title: Platelet-rich plasma fibrin glue for treatment of chylothorax following cavopulmonary connections
Description:
Abstract
OBJECTIVES
The postoperative persistence of chylothorax is a fatal complication of paediatric cardiac surgery.
There is an urgent need for an effective treatment of chylothorax.
This study reports the application of allogenic platelet-rich plasma fibrin glue (PRP-FG) as a conservative therapy before reoperation.
METHODS
Over a 9-year period, from 2010 to 2019, 27 patients with persistent chylothorax following a cavopulmonary connection, with a mean latency period of 11 days (range 10–15 days), were treated with PRP-FG.
These patients were selected because they had not responded positively to initial conservative management plans.
The patients were followed up for 9 years.
RESULTS
Twenty-five patients (92%) responded positively to treatment with PRP-FG; 2 patients did not respond to the treatment and died after reoperation.
All of the successfully treated patients in follow-up continued to live a healthy life without further complications.
CONCLUSIONS
Recalcitrant chylothorax that persists after paediatric cardiac surgery responded positively to treatment with PRP-FG.
This technique precluded the need for another operation and significantly decreased the morbidity and mortality rates.
Related Results
Blunt Chest Trauma and Chylothorax: A Systematic Review
Blunt Chest Trauma and Chylothorax: A Systematic Review
Abstract
Introduction: Although traumatic chylothorax is predominantly associated with penetrating injuries, instances following blunt trauma, as a rare and challenging condition, ...
Efeito do ácido tranexâmico associado à cola de fibrina sobre o reparo ósseo: estudo histológico em ratos
Efeito do ácido tranexâmico associado à cola de fibrina sobre o reparo ósseo: estudo histológico em ratos
O processo de reparação óssea é controlado por mecanismos moleculares complexos que envolvem fatores sistêmicos e locais. Os adesivos fibrínicos, também conhecidos como selantes de...
Comparative evaluation of mechanical properties of leukocyte rich platelet rich fibrin, advanced-platelet rich fibrin, titanium-platelet rich fibrin, selphyl platelet rich fibrin matrix and merisis platelet rich fibrin matrix
Comparative evaluation of mechanical properties of leukocyte rich platelet rich fibrin, advanced-platelet rich fibrin, titanium-platelet rich fibrin, selphyl platelet rich fibrin matrix and merisis platelet rich fibrin matrix
Purpose: The interest in mechanical properties of membranes derived from different autologous platelet concentrates (PCs) stems from the need to possess certain qualities to bring ...
PATHOPHYSIOLOGY OF THROMBOCYTOPENIA AND RESULTANT CLINICAL INDICATIONS FOR PLATELET TRANSFUSION
PATHOPHYSIOLOGY OF THROMBOCYTOPENIA AND RESULTANT CLINICAL INDICATIONS FOR PLATELET TRANSFUSION
Careful evaluation of platelet survival data in normal individuals and patients with thrombocytopeniasecondary to marrow aplasia has demonstrated that platelets are lost from circu...
Use of Erythropoietin and Fibrin Glue Mixture for Peripheral Nerve Repair
Use of Erythropoietin and Fibrin Glue Mixture for Peripheral Nerve Repair
Background:
Erythropoietin has neuroregenerative effects. Fibrin glue may be used for nerve repair and controlled release of substances. In this study, the authors inve...
Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface
Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface
A well-characterized in vitro model system composed of thrombin- stimulated gel-filtered human platelets, fibrin-(ogen), plasminogen, and recombinant tissue plasminogen activator (...
Cytology and histology characteristics of platelet-rich fibrin
Cytology and histology characteristics of platelet-rich fibrin
Background: Platelet-rich fibrin (PRF) is a biomaterial whose frame is a network of fibrin fibers containing cells from peripheral blood and growth factors. PRF biomaterials have g...
Abstract 1645: Characterization of a novel anti-insoluble-fibrin chimeric antibody (AFCA) for cancer stromal target (CAST) therapy and diagnosis.
Abstract 1645: Characterization of a novel anti-insoluble-fibrin chimeric antibody (AFCA) for cancer stromal target (CAST) therapy and diagnosis.
Abstract
Background: A large body of clinicopathological evidence supports the conclusion that abnormal coagulation occurs in a variety of cancers. In the non-malign...

